Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Eizen Joshua M
See Remarks at AN2 Therapeutics. Filing since 3 Jan 2025.
CIK 0001949621
Company
Date
Role
Action
Shares
Amount
Of holding
ANTX
AN2 Therapeutics, Inc.
8 Jul 2026
See Remarks
Sold at will
5,945
$24.80K
2.8%
ANTX
AN2 Therapeutics, Inc.
6 Jan 2026
See Remarks
Sold at will
6,931
$7.01K
4.3%
ANTX
AN2 Therapeutics, Inc.
5 Jan 2026
See Remarks
Sold at will
17,923
$17.95K
10.1%
ANTX
AN2 Therapeutics, Inc.
4 Nov 2025
See Remarks
Sold at will
2,819
$3.21K
1.6%
ANTX
AN2 Therapeutics, Inc.
3 Jan 2025
See Remarks
Sold at will
9,663
$12.96K
7.6%
5 decisions on file.
